Skip to content

Clinical trials

Phase 1/2 Leukemia, Megakaryoblastic, Acute trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Megakaryoblastic, Acute Phase: Phase 1/2 Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20072
20082
20091
20111
20131

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Terminated2
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)5
Fred Hutchinson Cancer Center2
Children's Oncology Group1
European Organisation for Research and Treatment of Cancer - EORTC1
H. Lee Moffitt Cancer Center and Research Institute1
M.D. Anderson Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Erythroblastic, Acute11
Leukemia, Megakaryoblastic, Acute11
Leukemia, Myeloid, Acute11
Leukemia, Monocytic, Acute9
Leukemia, Myelomonocytic, Acute9
Congenital Abnormalities7
Leukemia5
Myelodysplastic Syndromes4
Leukemia, Myelomonocytic, Chronic3
Anemia, Refractory, with Excess of Blasts2

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.